Here is this week’s news of grants and gifts that may be of particular interest to women in higher education.

The University of Tennessee Health Science Center in Memphis received a $924,000 grant from the U.S. Department of Defense to develop a new treatment for ovarian cancer. A new drug called sabizabulin is currently undergoing clinical trials, and now, the team is set to test a newer version of this drug against metastatic and drug-resistant ovarian cancer.
North Carolina State University was recently awarded a $3.2 million grant from the National Institute of Child Health and Development, a unit of the National Institutes of Health, to study female reproductive aging and uterine health. Advanced maternal age is generally defined as over 35 years old and can play a critical role in adverse pregnancy outcomes. These issues include infertility, miscarriage, stillbirth, preterm birth, preeclampsia, gestational diabetes, and mortality.


